This contract involves expanding the existing Comarch Optimed NXT system with additional functionalities. The key components of the project include: 1. Enhancing the Pathology module to enable the electronic sharing of results. 2. Expanding the Comarch Optimed NXT system to allow for bulk signing an
Tender closed on 10 Mar 2026. Awaiting award.
This contract involves the expansion of IT systems to integrate with the Intelligent Services Platform (PUI) along with 36 months of technical support. The detailed scope includes: 1) For Package 1: a) Conducting analytical and design work related to connecting the Infinitt PACS system and Netgate A
This contract involves the supply of infusion fluids as detailed in the pricing form, which is attached as Annex 3 to the procurement documentation. Suppliers are invited to provide these essential health products to the specified healthcare facility. The deadline for submissions is January 13, 2026
This contract involves the supply of laboratory reagents along with the leasing of analyzers, as well as the provision of reagents and utensils for the Pathomorphology Department. Suppliers are required to refer to Annex 3 of the procurement documentation for detailed specifications regarding packag
This contract involves the supply of disposable medical equipment and hematological products for the Provincial Specialist Hospital named after Stefan Cardinal Wyszyński in Lublin. Suppliers can submit partial offers for 28 different packages, as detailed in the pricing and assortment form (Annex 3
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
